The Food and Drug Administration holds a two-day meeting beginning Monday to examine the latest research on anti-inflammatory medicines called NSAIDS, which serve as the backbone of U.S. pain treatment.
The key question is:
- whether naproxen — the key ingredient in Bayer's Aleve and many other generic pain pills
— carries a lower risk of heart attack and stroke than rival medications,
- like ibuprofen, sold as Advil by Pfizer and Motrin by Johnson & Johnson, among others.
- naproxen = aleve = anaprox = apronax = naprelan = naprosyn >
- ibuprophen = advil = motrin = brufen = caldolor = emuProfen = nurofen = anadin >
- paracetamol = acetaminophen = APAP = tylenol = anacin [aspirin free] = apra = feverall = genapap